Reference
[1] Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China[J]. JAMA Cardiol, 2020.
[2] Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study[J]. The Lancet, 2020,395(10229):1054-1062.
[3] Galie N, Humbert M, Vachiery J L, et al. [2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension][J]. Kardiol Pol, 2015,73(12):1127-1206.
[4] Peiris J, Chu C M, Cheng V, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study[J]. The Lancet, 2003,361(9371):1767-1772.
[5] Hong K H, Choi J P, Hong S H, et al. Predictors of mortality in Middle East respiratory syndrome (MERS)[J]. Thorax, 2018,73(3):286-289.
[6] Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) [J]. JAMA Cardiol, 2020, [Epub ahead of print].
[7] Inciardi R M, Lupi L, Zaccone G, et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)[J]. JAMA Cardiol, 2020.
[8] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. The Lancet, 2020,395(10223):497-506.
[9] Madjid M, Vela D, Khalili-Tabrizi H, et al. Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes[J]. Tex Heart Inst J, 2007,34(1):11-18.
[10] Namendys-Silva S, Santos-Martínez L, Pulido T, et al. Pulmonary Hypertension Associated With Acute Respiratory Distress Syndrome[J]. Chest, 2013,144(4, Supplement):376A.
[11] Squara P, Dhainaut J F, Artigas A, et al. Hemodynamic profile in severe ARDS: results of the European Collaborative ARDS Study[J]. Intensive Care Med, 1998,24(10):1018-1028.
[12] Osman D, Monnet X, Castelain V, et al. Incidence and prognostic value of right ventricular failure in acute respiratory distress syndrome[J]. Intensive Care Med, 2009,35(1):69-76.
[13] Li S S, Cheng C W, Fu C L, et al. Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study[J]. Circulation, 2003,108(15):1798-1803.
[14] Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study[J].Lancet, 2003,361(9371):1767-72.
Figure legend:
Figure1 .A female patient, 77years old, was admitted to WuHan Lei Shen Shan hospital with fatigue and right abdominal pain for 30 days.Echocardiography showed that the left atrium was enlarged, the movement of the ventricular wall decreased, and the left ventricular systolic function decreased.
Figure2、3 . A male patient, 81 years old, was admitted to WuHan Lei Shen Shan hospital with cough and chest stuffiness for 2 weeks.Echocardiography showed pericardial effusion (9mm behind the left posterior wall of the left ventricle), mild tricuspid regurgitation, maximum reflux pressure about 36mmHg, and pulmonaryarterialsystolicpressure was estimated to be about 46mmHg,therefore this patient has mild pulmonary hypertension.
Figure 4 Dynamic changes of cardiac biomarkers during hospitalization. Figure shows dynamic changes in high-sensitivity cardiac troponin I (ng/ml)(A), Brain natriuretic peptide (pg/ml)(B), Creatine kinase MB (C), Lactate dehydrogenase (U/L) (D), α - hydroxybutyrate dehydrogenase(E).